background image

Paid Clinical Trials New Haven

Discover 1,099 paid clinical trials in New Haven, Connecticut. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors

for
Advanced or Metastatic Solid Tumors, Breast Cancer,
Location: 21 recruiting locations
Sponsor: IDEAYA Biosciences

Sex: All

Age: 18+

Code: NCT05787587

Phase1, Recruiting
Active & Responsive

Pharmacological and Behavioral Treatment After Bariatric Surgery: Acute (Stage 1)

for
Loss-of-control Eating, Obesity/Overweight
Location: 1 recruiting location
Sponsor: Yale University

Sex: All

Age: 18 - 70

Code: NCT04599478

Phase2, Phase3, Recruiting
Active & Responsive

Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis

for
Intracranial Arteriosclerosis, Stroke
Location: 77 recruiting locations
Sponsor: University of Florida

Sex: All

Age: 30+

Code: NCT05047172

Phase3, Recruiting
Active & Responsive

A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

for
Alzheimers Disease, Dementia, Alzheimers Disease, Familial
Location: 14 recruiting locations
Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT06647498

Phase2, Phase3, Recruiting
Active & Responsive

Sleep for Stroke Management and Recovery Trial

for
Ischemic Stroke, Sleep Apnea, Sleep Apnea, Obstructive, Stroke,
Location: 71 recruiting locations
Sponsor: University of Michigan

Sex: All

Age: 18+

Code: NCT03812653

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Neurophysiological Benefits of Live Music for Early Alzheimer's Patients and Their Caregivers

for
Alzheimer Disease, Dementia, Mild Cognitive Impairment,
Location: 1 recruiting location
Sponsor: Yale University

Sex: All

Age: 50 - 70+

Code: NCT06940687

Recruiting
Active & Responsive

First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer

for
PIK3CA Mutation, Solid Tumor, Adult,
Location: 19 recruiting locations
Sponsor: Relay Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05216432

Phase1, Recruiting
Active & Responsive

A Study to Evaluate Safety, Pharmacokinetics, and Activity of GDC-7035 as a Single Agent and in Combination in Patients With Advanced Solid Tumors

for
Solid Tumor
Location: 13 recruiting locations
Sponsor: Genentech, Inc.

Sex: All

Age: 18+

Code: NCT06619587

Phase1, Recruiting
Active & Responsive

FOG-001 in Locally Advanced or Metastatic Solid Tumors

for
Cancer, Colorectal Cancer, Solid Tumor,
Location: 18 recruiting locations
Sponsor: Parabilis Medicines, Inc.

Sex: All

Age: 18+

Code: NCT05919264

Phase1, Phase2, Recruiting
Active & Responsive

A Phase II Evaluation of Afatinib in Patients With Persistent or Recurrent HER2-positive Uterine Serous Carcinoma

for
HER2/Neu+ Uterine Serous Carcinoma
Location: 1 recruiting location
Sponsor: Yale University

Sex: Female

Age: 18 - 70+

Code: NCT02491099

Phase2, Recruiting